Metabolites of Geum aleppicum and Sibbaldianthe bifurca : Diversity and α-Glucosidase Inhibitory Potential
α-Glucosidase inhibitors are essential in the treatment of diabetes mellitus. Plant-derived drugs are promising sources of new compounds with glucosidase-inhibiting ability. The Jacq. and (L.) Kurtto & T.Erikss. herbs are used in many traditional medical systems to treat diabetes. In this study,...
Saved in:
Published in | Metabolites Vol. 13; no. 6; p. 689 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
25.05.2023
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | α-Glucosidase inhibitors are essential in the treatment of diabetes mellitus. Plant-derived drugs are promising sources of new compounds with glucosidase-inhibiting ability. The
Jacq. and
(L.) Kurtto & T.Erikss. herbs are used in many traditional medical systems to treat diabetes. In this study, metabolites of the
and
herbs in active growth, flowering, and fruiting stages were investigated using high-performance liquid chromatography with photodiode array and electrospray ionization triple quadrupole mass spectrometric detection (HPLC-PDA-ESI-tQ-MS/MS). In total, 29 compounds in
and 41 components in
were identified including carbohydrates, organic acids, benzoic and ellagic acid derivatives, ellagitannins, flavonoids, and triterpenoids. Gemin A, miquelianin, niga-ichigoside F1, and 3,4-dihydroxybenzoic acid 4-
-glucoside were the dominant compounds in the
herb, while guaiaverin, miquelianin, tellimagrandin II
, casuarictin, and glucose were prevailing compounds in the
herb. On the basis of HPLC activity-based profiling of the
herb extract, the most pronounced inhibition of α-glucosidase was observed for gemin A and quercetin-3-
-glucuronide. The latter compound and quercetin-3-
-arabinoside demonstrated maximal inhibition of α-glucosidase in the
herb extract. The obtained results confirm the prospects of using these plant compounds as possible sources of hypoglycemic nutraceuticals. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2218-1989 2218-1989 |
DOI: | 10.3390/metabo13060689 |